Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota ; volume:10 ; number:1 ; day:17 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
npj Biofilms and Microbiomes ; 10, Heft 1 (17.9.2024), 1-13, 12.2024

Creator: Anjou, Cyril
Royer, Marie
Bertrand, Émilie
Bredon, Marius
Le Bris, Julie
Salgueiro, Iria Alonso
Caulat, Léo C.
Dupuy, Bruno
Barbut, Frédéric
Morvan, Claire
Rolhion, Nathalie
Martin-Verstraete, Isabelle

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41522-024-00551-3

URN: urn:nbn:de:101:1-2411302102591.568398655987

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Anjou, Cyril
Royer, Marie
Bertrand, Émilie
Bredon, Marius
Le Bris, Julie
Salgueiro, Iria Alonso
Caulat, Léo C.
Dupuy, Bruno
Barbut, Frédéric
Morvan, Claire
Rolhion, Nathalie
Martin-Verstraete, Isabelle
SpringerLink (Online service)

Other Objects (12)

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Applications of Fecal Microbiota Transplantation: Emphasis on Clostridioides difficile Infections

Microbiota-based markers predictive of development of Clostridioides difficile infection

Fecal Microbiota Transplantation Is Effective for Postcolectomy Recurrent Clostridioides difficile Infection

Patient Education: Clostridioides difficile Infection

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Related objects

Reset password